#Japan #Tokyo #Sleep Quality #CBD Oil #Astrasana Japan

Astrasana Japan's Pilot Study on CBD Oil's Effect on Sleep Quality

In a groundbreaking initiative, Astrasana Japan, a subsidiary of the Swiss cannabinoid company Astrasana Group, has conducted a pilot study aimed at understanding the impact of CBD oil on sleep quality among adult women facing sleep-related issues. Collaborating with pharmacists and a Doctor of Pharmacy, the research focused on women visiting pharmacy clinics with complaints about their sleep.

Background of the Study

Sleep disorders present a significant challenge in Japan, particularly affecting women's quality of life (QOL) due to hormonal fluctuations across various life stages, such as during the menstrual cycle or menopause. These fluctuations often lead to disruptions in the autonomic nervous system and subsequent sleep disturbances. This pilot study was designed to evaluate whether high-quality Swiss CBD oil could serve as a viable self-care option for these women.

Study Overview

• - Participants: Adult women aged 20 to 69 experiencing sleep issues.
• - Duration: 4 weeks of intervention.
• - Product Used: Swisscan® 20% PURE CBD Oil.
• - Dosage: 3 drops (approximately 20mg of CBD) taken sublingually before bedtime, once daily.
• - Evaluation Method: Participants completed the Pittsburgh Sleep Quality Index (PSQI) before and four weeks after starting the CBD oil.

Key Findings

The analysis of responses from 16 participants revealed some important trends:

• - Improvement in Sleep Quality: The average PSQI score decreased from 11.44 prior to consumption to 10.69 post 4 weeks, indicating a significant improvement in sleep quality.
• - Approximately 60% of participants showed a reduction in their scores; some improved enough to move from a classification of "sleep disorder present" to "no disorder."
• - Specific PSQI categories related to nighttime awakenings and daytime motivation also demonstrated a trend toward improvement after four weeks of CBD consumption.

```plaintext
Figure 1: Sleep Quality Improvement
```

Discussion

This pilot study suggests that continuous intake of low dosages (approximately 20mg per day) of CBD oil may help improve sleep quality among adult women. Particularly noteworthy was the reduction in nighttime awakenings, which could be attributed to CBD's anxiolytic properties and its regulatory effects on the autonomic nervous system via the Endocannabinoid System (ECS). The resultant improvement in sleep could lead to enhanced daytime motivation and overall activity levels.

Future Prospects

Building on the insights gained from this pilot study, Astrasana Japan plans to strengthen various initiatives, including:

• - Evidence-based Product Development: Developing products tailored to sleep support and women’s health issues in the femtech domain.
• - Larger Clinical Trials: Expanding participant numbers for future research and considering the collection of objective data using wearable devices to enhance reliability.
• - Proper Information Dissemination and Awareness: Focused efforts on spreading knowledge about CBD and the importance of the ECS within the framework of Japan’s evolving cannabis regulations.

Astrasana Japan is committed to its vision of ensuring safety through evidence-based approaches while delivering high-quality hemp-derived products. By utilizing premium Swiss materials and a scientific methodology, the company aims to contribute significantly to the wellness of the Japanese populace.

For further inquiries, please contact:
Astrasana Japan
1-14-14 Tomigaya, Shibuya, Tokyo 151-0063
Email: [email protected]
Website: Astrasana Japan

About Astrasana Group

Headquartered in Zurich, Switzerland, the Astrasana Group operates subsidiaries in the Czech Republic, the UK, and Japan. With approximately 40 specialists on board, it provides comprehensive services related to medical cannabis research, distribution, CBD ingredient supply, and wellness products for pets, serving over 18 markets worldwide. Boasting a robust quality management system developed under strict European regulations, Astrasana Group continues to contribute to the healthy development of the international cannabinoid market.

Product Information

• - Product Name: swisscan® 20% PURE CBD Oil
• - CBD Content: 20%
• - Country of Manufacture: Japan
• - Volume: 10ml
• - Key Ingredients: CBD, Coconut-derived MCT oil
• - Description: An advanced broad-spectrum model enriched with high concentrations of Swiss CBD isolate.

For more information on the product, visit the official catalog or check our official Instagram!